reported that circACTN4 can competitively bind to far upstream element-binding protein 1 (FUBP1) to prevent FUBP1 from binding to FIR, thereby activating MYC transcription and promoting tumor progression in breast cancer (158). The gene discussed is FUBP1; the disease is breast carcinoma.